Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:06 am
Author: Getaka|Social: XLinkedIn

Indraprastha Medical Corporation Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹348.53Overvalued by 12.87%vs CMP ₹400.00

P/E (20.0) × ROE (30.0%) × BV (₹71.80) × DY (1.13%)

₹258.20Overvalued by 35.45%vs CMP ₹400.00
MoS: -54.9% (Negative)Confidence: 58/100 (Moderate)Models: 1 Under, 1 Fair, 7 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹437.6623%Fair (+9.4%)
Graham NumberEarnings₹179.5217%Over (-55.1%)
Earnings PowerEarnings₹109.2711%Over (-72.7%)
DCFCash Flow₹486.7711%Under (+21.7%)
Net Asset ValueAssets₹71.947%Over (-82%)
EV/EBITDAEnterprise₹312.129%Over (-22%)
Earnings YieldEarnings₹199.507%Over (-50.1%)
ROCE CapitalReturns₹15.137%Over (-96.2%)
Revenue MultipleRevenue₹148.036%Over (-63%)
Consensus (9 models)₹258.20100%Overvalued
Key Drivers: EPS CAGR 25.6% lifts DCF — verify sustainability. | Wide model spread (₹15–₹487) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 25.6%

*Investments are subject to market risks

Investment Snapshot

74
Indraprastha Medical Corporation Ltd scores 74/100 (Strong)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health88/100 · Strong
ROCE 39.1% ExcellentROE 30.0% ExcellentD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money40/100 · Moderate
FII holding stable No changeDII holding down 2.74% MF sellingPromoter holding at 51.0% Stable
Earnings Quality65/100 · Strong
OPM expanding (14% → 17%) Improving
Quarterly Momentum68/100 · Strong
Revenue (4Q): +9% YoY GrowingProfit (4Q): +21% YoY Positive
Industry Rank90/100 · Strong
P/E 20.0 vs industry 75.2 Cheaper than peersROCE 39.1% vs industry 14.7% Above peersROE 30.0% vs industry 13.9% Above peers3Y sales CAGR: 15% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:06 am

Market Cap 3,664 Cr.
Current Price 400
Intrinsic Value₹258.20
High / Low 641/322
Stock P/E20.0
Book Value 71.8
Dividend Yield1.13 %
ROCE39.1 %
ROE30.0 %
Face Value 10.0
PEG Ratio0.78

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Indraprastha Medical Corporation Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Indraprastha Medical Corporation Ltd 3,664 Cr. 400 641/32220.0 71.81.13 %39.1 %30.0 % 10.0
Artemis Medicare Services Ltd 3,528 Cr. 223 306/20335.5 56.00.20 %14.9 %12.9 % 1.00
Thyrocare Technologies Ltd 5,762 Cr. 362 538/22043.8 32.41.93 %26.5 %17.4 % 10.0
Shalby Ltd 1,507 Cr. 140 275/126187 92.80.00 %6.12 %0.62 % 10.0
Sakar Healthcare Ltd 1,147 Cr. 516 578/22045.5 1360.00 %8.54 %6.48 % 10.0
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Indraprastha Medical Corporation Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 277274307317306315348350325334365381372
Expenses 240241259267259266281286273272292310310
Operating Profit 37334750474867645261737162
OPM % 13%12%15%16%15%15%19%18%16%18%20%19%17%
Other Income 3544455656777
Interest 1111122221221
Depreciation 10101010101011111111101111
Profit before tax 29274044414260574555686656
Tax % 29%27%24%25%28%25%25%26%26%26%25%25%27%
Net Profit 21203033293145423341514941
EPS in Rs 2.282.163.333.583.213.404.884.633.584.475.615.404.47

Last Updated: February 5, 2026, 1:08 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 1:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 6787147557667537888316138881,0991,2451,3561,451
Expenses 5876306756866787067435727689471,0501,1121,184
Operating Profit 9185807974828741120152195245268
OPM % 13%12%11%10%10%10%11%7%14%14%16%18%18%
Other Income 111-0-1-1-0-0-39162228
Interest 10878976334466
Depreciation 28283531313033333539404443
Profit before tax 54503941344548479117166216246
Tax % 35%34%37%36%38%36%9%46%26%26%25%26%
Net Profit 3532242621284425986124161183
EPS in Rs 3.873.542.662.862.303.104.760.256.399.4013.5217.5619.95
Dividend Payout % 47%51%68%63%65%52%0%0%39%32%33%26%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-8.57%-25.00%8.33%-19.23%33.33%57.14%-95.45%2850.00%45.76%44.19%29.84%
Change in YoY Net Profit Growth (%)0.00%-16.43%33.33%-27.56%52.56%23.81%-152.60%2945.45%-2804.24%-1.58%-14.35%

Indraprastha Medical Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:10%
3 Years:15%
TTM:7%
Compounded Profit Growth
10 Years:17%
5 Years:29%
3 Years:37%
TTM:21%
Stock Price CAGR
10 Years:24%
5 Years:58%
3 Years:89%
1 Year:8%
Return on Equity
10 Years:19%
5 Years:23%
3 Years:28%
Last Year:30%

Last Updated: September 5, 2025, 7:30 am

Balance Sheet

Last Updated: December 10, 2025, 2:51 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 92929292929292929292929292
Reserves 95103132139141152176181234288386505567
Borrowings 6350526766214352343331
Other Liabilities 199196185160134157177157131173212222264
Total Liabilities 449442460458432422449432462555723852954
Fixed Assets 293286301296294280303283277275347328351
CWIP 23300103030332
Investments 00000000000039
Other Assets 154153157163138141146145185278376491563
Total Assets 449442460458432422449432462555723852954

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 586462284875862794144200157
Cash from Investing Activity + -22-29-33-22-30-17-40-19-74-108-158-111
Cash from Financing Activity + -36-35-30-5-17-44-43-3-3-26-32-46
Net Cash Flow 0-0-0-01144517119-0
Free Cash Flow 3635295175846665100131120
CFO/OP 82%98%104%57%82%110%113%88%95%102%127%89%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow28.0035.0028.0012.008.0061.0083.0038.00115.00150.00161.00212.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 354041474135354018231720
Inventory Days
Days Payable
Cash Conversion Cycle 354041474135354018231720
Working Capital Days -27-35-22-17-7-5-10-1-2-12-24-19
ROCE %26%23%18%17%15%19%21%3%29%34%38%39%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%
FIIs 0.27%0.37%0.81%0.95%1.08%1.70%2.64%2.88%2.94%2.73%2.41%2.72%
DIIs 0.00%0.00%6.71%6.36%4.91%3.14%3.19%3.18%3.56%3.56%3.51%0.82%
Public 48.72%48.62%41.49%41.69%43.01%44.14%43.16%42.91%42.50%42.74%43.08%45.43%
No. of Shareholders 49,83348,63047,86551,44854,15855,10364,67169,69770,49170,21170,91471,225

Shareholding Pattern Chart

No. of Shareholders

Indraprastha Medical Corporation Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Small Cap Fund 721,778 0.14 43.77N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 17.5613.529.406.390.25
Diluted EPS (Rs.) 17.5613.529.406.390.25
Cash EPS (Rs.) 22.4017.8913.6810.213.89
Book Value[Excl.RevalReserv]/Share (Rs.) 65.0952.1241.3935.5029.75
Book Value[Incl.RevalReserv]/Share (Rs.) 65.0952.1241.3935.5029.75
Dividend / Share (Rs.) 4.504.503.002.500.00
Revenue From Operations / Share (Rs.) 147.96135.78119.8596.8966.91
PBDIT / Share (Rs.) 29.1222.9317.5312.814.47
PBIT / Share (Rs.) 24.2818.5613.259.000.83
PBT / Share (Rs.) 23.6018.1212.788.630.46
Net Profit / Share (Rs.) 17.5613.529.406.390.25
PBDIT Margin (%) 19.6716.8914.6213.226.67
PBIT Margin (%) 16.4113.6711.059.281.24
PBT Margin (%) 15.9413.3410.668.900.69
Net Profit Margin (%) 11.869.957.846.600.37
Return on Networth / Equity (%) 26.9825.9422.7018.010.85
Return on Capital Employeed (%) 33.0730.5028.5422.402.41
Return On Assets (%) 18.9017.1315.5112.690.53
Asset Turnover Ratio (%) 1.721.952.161.991.39
Current Ratio (X) 2.411.861.721.681.22
Quick Ratio (X) 2.371.821.661.581.14
Inventory Turnover Ratio (X) 186.830.0021.0018.5510.95
Dividend Payout Ratio (NP) (%) 25.6222.1826.600.000.00
Dividend Payout Ratio (CP) (%) 20.0916.7618.270.000.00
Earning Retention Ratio (%) 74.3877.8273.400.000.00
Cash Earning Retention Ratio (%) 79.9183.2481.730.000.00
Interest Coverage Ratio (X) 42.5751.7937.5534.4312.27
Interest Coverage Ratio (Post Tax) (X) 26.6831.5321.1318.191.70
Enterprise Value (Cr.) 3217.171350.00583.80467.36465.22
EV / Net Operating Revenue (X) 2.371.080.530.520.75
EV / EBITDA (X) 12.056.423.633.9811.36
MarketCap / Net Operating Revenue (X) 2.611.260.640.600.80
Retention Ratios (%) 74.3777.8173.390.000.00
Price / BV (X) 5.933.301.881.651.81
Price / Net Operating Revenue (X) 2.611.260.640.600.80
EarningsYield 0.040.070.120.100.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Indraprastha Medical Corporation Ltd. is a Public Limited Listed company incorporated on 16/03/1988 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L24232DL1988PLC030958 and registration number is 030958. Currently company belongs to the Industry of Hospitals & Medical Services. Company's Total Operating Revenue is Rs. 1356.36 Cr. and Equity Capital is Rs. 91.67 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesSarita Vihar, New Delhi Delhi 110076Contact not found
Management
NamePosition Held
Dr. Prathap C ReddyVice Chairman
Mr. Shivakumar PattabhiramanManaging Director
Mr. Sudhir JalanDirector
Prof. (Dr) Mahesh VermaDirector
Mr. Salil SinghalDirector
Dr.(Ms.) Suneeta ReddyDirector
Mr. Vinayak ChatterjeeDirector
Ms. Vineeta RaiDirector
Mr. Sandip SomanyDirector
Mr. Tejpreet Singh ChopraDirector
Ms. Madhumita GanguliDirector
Dr.(Ms.) Sangita ReddyDirector

FAQ

What is the intrinsic value of Indraprastha Medical Corporation Ltd and is it undervalued?

As of 17 April 2026, Indraprastha Medical Corporation Ltd's intrinsic value is ₹258.20, which is 35.45% lower than the current market price of ₹400.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (30.0 %), book value (₹71.8), dividend yield (1.13 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Indraprastha Medical Corporation Ltd?

Indraprastha Medical Corporation Ltd is trading at ₹400.00 as of 17 April 2026, with a FY2026-2027 high of ₹641 and low of ₹322. The stock is currently near its 52-week low. Market cap stands at ₹3,664 Cr..

How does Indraprastha Medical Corporation Ltd's P/E ratio compare to its industry?

Indraprastha Medical Corporation Ltd has a P/E ratio of 20.0, which is below the industry average of 75.17. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Indraprastha Medical Corporation Ltd financially healthy?

Key indicators for Indraprastha Medical Corporation Ltd: ROCE of 39.1 % indicates efficient capital utilization; ROE of 30.0 % shows strong shareholder returns. Dividend yield is 1.13 %.

Is Indraprastha Medical Corporation Ltd profitable and how is the profit trend?

Indraprastha Medical Corporation Ltd reported a net profit of ₹161 Cr in Mar 2025 on revenue of ₹1,356 Cr. Compared to ₹59 Cr in Mar 2022, the net profit shows an improving trend.

Does Indraprastha Medical Corporation Ltd pay dividends?

Indraprastha Medical Corporation Ltd has a dividend yield of 1.13 % at the current price of ₹400.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Indraprastha Medical Corporation Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports